SONOLASTIC NP1 CARB OFF WHITE PPK

BASF CORPORATION

Revision date : 2010-09-07

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

Note: Ingredients listed on restricted chemical lists

EC/CAS

13463-67-7

Name of the chemical

Reaction mass of titanium dioxide and silver chloride

Concentration

3.0-7.0%

EC/CAS

8052-41-3

Name of the chemical

Stoddard Solvent; Naphtha (petroleum), hydrodesulfurized heavy

Concentration

1.0-5.0%

Listed in

EC/CAS

14807-96-6

Name of the chemical

Talc

Concentration

1.0-5.0%

EC/CAS

1305-78-8

Name of the chemical

Calcium oxide

Concentration

1.0-5.0%

EC/CAS

584-84-9

Name of the chemical

2,4-Diisocyanattoluol

Concentration

0.1-1.0%

EC/CAS

14808-60-7

Name of the chemical

Silica, crystalline

Concentration

0.1-1.0%

General Information

Version

1.1

Revision date

2010-09-07

Product name

SONOLASTIC NP1 CARB OFF WHITE PPK

1.2.1 Relevant identified uses

Product for construction chemicals

Emergency telephone

1-800-424-9300

Icons in SDS

Company Information

company name

BASF CORPORATION

GHS Information

Signal word

WARNING

Section 2

SECTION 2: Hazards identification

Emergency overview WARNING: COMBUSTIBLE. HARMFUL IF INHALED. SENSITIZATION CAN OCCUR IN SOME INDIVIDUALS, LEADING TO ASTHMA-LIKE SPASMS OF THE BRONCHIAL TUBES AND DIFFICULTY BREATHING. INDIVIDUALS WITH A HISTORY OF RESPIRATORY ILLNESS, ASTHMATIC CONDITIONS, EYE DAMAGE OR TDI SENSITIZATION SHOULD NOT BE EXPOSED TO THIS PRODUCT. TDI IS INCLUDED IN THE NTP ANNUAL REPORT ON CARCINOGENS. RESULTS FROM A TDI HEALTH STUDY INDICATE THAT OVEREXPOSURE TO A RESPIRATORY IRRITANT, RESULTING IN LOWER RESPIRATORY TRACT SYMPTOMS COULD INCREASE THE RISKS OF DEVELOPING ASTHMA-LIKE REACTIONS FROM SUBSEQUENT TDI EXPOSURE. CONTAINS MATERIAL WHICH CAN CAUSE CANCER. Irritating to eyes, respiratory system and skin. Avoid contact with the skin, eyes and clothing. Avoid sources of ignition. No exposure to respirable Crystalline (quartz) Silica anticipated with recommended use of product. State of matter: solid Colour: pigmented Odour: slight odour

Principle Routes of Exposure

Routes of entry for solids and liquids include eye and skin contact, ingestion and inhalation. Routes of entry for gases include inhalation and eye contact. Skin contact may be a route of entry for liquified gases. Acute toxicity: May be harmful if inhaled. Irritation / corrosion: Irritating to eyes, respiratory system and skin. Sensitization: Sensitization after skin contact possible. The substance may cause sensitization of the respiratory tract. Chronic toxicity: Repeated dose toxicity: Overexposure may cause CNS depression including headache, dizziness, nausea and loss of consciousness.

Medical Conditions Generally Aggravated by Exposure

overexposure The isocyanate component is a respiratory sensitizer. It may cause allergic reaction leading to asthma-like spasms of the bronchial tubes and difficulty in breathing. Persons with history of respiratory disease or hypersensitivity should not be exposed to this product. Medical supervision of all employees who handle or come into contact with isocyanates is recommended. Preemployment and periodic medical examinations with respiratory function tests (FEV, FVC as a minimum) are suggested. Persons with asthmatic conditions, chronic bronchitis, other chronic respiratory diseases, recurrent eczema or pulmonary sensitization should be excluded from working with isocyanates. Once a person is diagnosed as having pulmonary sensitization (allergic asthma) to isocyanates, further exposure is not recommended. Contact may aggravate pulmonary disorders. Signs and symptoms of overexposure: In sensitized individuals, sensitization reactions may be elicited by structurally similar substances. Respiratory sensitization may result in allergic (asthma-like) signs in the lower respiratory tract including wheezing, shortness of breath and difficulty breathing, the onset of which may be delayed. Repeated inhalation of high concentrations may cause lung damage, including reduced lung function, which may be permanent. Substances eliciting lower respiratory tract irritation may worsen the asthma-like reactions that may be produced by product exposures.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.